Form 4 for LUNG Pulmonx Corp
Accepted 2026-09-03 18:23:50 ET · period of report 2026-09-01 · accession 0001805624-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-03 18:23 | 2026-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $2.26 | -41.9K | 1.14M | -4% | -$94.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | S | D | 4,098 | $2.26 | 1,175,720 | D | — | — | (F1) These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. (F2) Includes 1,656 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 14, 2026. |
| 2 | Common | Common Stock | 2026-09-01 | S | D | 37,784 | $2.26 | 1,137,936 | D | — | — | (F3) These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on December 1, 2025. |